These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37457326)

  • 41. [Erdheim-Chester disease: a non-Langerhans cell histiocytosis. A clinical-case and review of the literature].
    Valentini D; Cappelli C; Mizzoni F; Noto C; Toscano D; Foco M; Trasimeni G
    Clin Ter; 2004 May; 155(5):205-8. PubMed ID: 15344569
    [TBL] [Abstract][Full Text] [Related]  

  • 42. F-18 FDG PET/CT detects muscle involvement in Erdheim-Chester disease.
    Ambrosini V; Savelli F; Merli E; Zompatori M; Nanni C; Allegri V; Fanti S
    Clin Nucl Med; 2012 Feb; 37(2):196-7. PubMed ID: 22228352
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Erdheim-Chester disease: expanding the spectrum of cutaneous manifestations.
    Kobic A; Shah KK; Schmitt AR; Goyal G; Go RS; Guo R; Rech KL; Sartori-Valinotti JC;
    Br J Dermatol; 2020 Feb; 182(2):405-409. PubMed ID: 31120137
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pulmonary manifestations of Erdheim-Chester disease: clinical characteristics, outcomes and comparison with Langerhans cell histiocytosis.
    Wang JN; Wang FD; Sun J; Liang ZY; Li J; Zhou DB; Tian X; Cao XX
    Br J Haematol; 2021 Sep; 194(6):1024-1033. PubMed ID: 34423426
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Non-sclerotic bone involvement in Erdheim-Chester: PET/CT and MRI findings in a 15-year-old boy.
    White TV; Silvester NC; Otero HJ
    Pediatr Radiol; 2016 Aug; 46(9):1345-9. PubMed ID: 27028532
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tocilizumab in patients with multisystem Erdheim-Chester disease.
    Berti A; Cavalli G; Guglielmi B; Biavasco R; Campochiaro C; Tomelleri A; Nicoletti R; Panzacchi A; Ferrarini M; Dagna L
    Oncoimmunology; 2017; 6(6):e1318237. PubMed ID: 28680751
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiac Tamponade as the First Manifestation of Erdheim-Chester Disease.
    Costa IBSDS; Costa FAS; Bittar CS; Rizk SI; Abdo ANR; Siqueira SAC; Rocha V; Pereira J; Ky B; Hajjar LA
    JACC CardioOncol; 2020 Jun; 2(2):324-328. PubMed ID: 34396240
    [No Abstract]   [Full Text] [Related]  

  • 48. FDG PET/CT Findings of Erdheim-Chester Disease: Radiologic Response to a Novel Treatment Regimen.
    Akin EA; Osman M; Ellenbogen AL
    Clin Nucl Med; 2018 May; 43(5):337-340. PubMed ID: 29485431
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Case report: Targeted treatment strategies for Erdheim-Chester disease.
    Gulyás A; Pinczés LI; Mátyus J; Végh E; Bedekovics J; Tóth J; Barna S; Hunya Z; Szabó IL; Gazdag A; Illés Á; Magyari F
    Front Oncol; 2024; 14():1305518. PubMed ID: 38549927
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardiac involvement in Erdheim- Chester disease: MRI findings and literature revision.
    Ponsiglione A; Puglia M; Barbuto L; Solla R; Altiero M; Lubrano V; Imbriaco M
    Acta Radiol Open; 2015 Sep; 4(9):2058460115592273. PubMed ID: 26405559
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical and positron emission tomography responses to long-term high-dose interferon-α treatment among patients with Erdheim-Chester disease.
    Cao XX; Niu N; Sun J; Cai H; Wang FD; Wang YN; Duan MH; Zhou DB; Li J
    Orphanet J Rare Dis; 2019 Jan; 14(1):11. PubMed ID: 30630516
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Unusual manifestation of Erdheim-Chester disease.
    Pan A; Doyle T; Schlup M; Lubcke R; Schultz M
    BMC Gastroenterol; 2011 Jun; 11():77. PubMed ID: 21693070
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Erdheim Chester disease presented isolated breast and axillary involvement.
    Basara I; Yavuz E; Balci P; Tuna EB; Sari I
    JBR-BTR; 2015 Apr; 98(2):82-84. PubMed ID: 30394424
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiothoracic manifestations of Erdheim-Chester disease.
    Das JP; Xie L; Riedl CC; Hayes SA; Ginsberg MS; Halpenny DF
    Br J Radiol; 2019 Dec; 92(1104):20190473. PubMed ID: 31386554
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Erdheim-Chester disease: look it in the eye. An orbital magnetic resonance imaging study.
    Haroche J; Gueniche Y; Galanaud D; Cohen-Aubart F; Dormont D; Rousseau T; Amoura Z; Touitou V; Shor N
    Haematologica; 2022 Nov; 107(11):2667-2674. PubMed ID: 35484665
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical presentation, imaging and response to interferon-alpha therapy in Erdheim-Chester disease: case-based review.
    Iaremenko O; Petelytska L; Dyadyk O; Negria N; Fedkov D
    Rheumatol Int; 2020 Sep; 40(9):1529-1536. PubMed ID: 32572610
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Atypical Bone Involvement in Erdheim-Chester Disease Showing No or Subtle Structure Changes and Increased Activity on FDG PET/CT.
    Xiao Z; Dai S; Dong A; Bai Y
    Clin Nucl Med; 2024 Nov; 49(11):1055-1057. PubMed ID: 38968579
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Erdheim-Chester Disease Involving the Central Nervous System with the Unique Appearance of a Coated Vertebral Artery.
    Suzuki H; Wanibuchi M; Komatsu K; Akiyama Y; Mikami T; Sugita S; Hasegawa T; Kaya M; Takada K; Mikuni N
    NMC Case Rep J; 2016 Oct; 3(4):125-128. PubMed ID: 28664013
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Erdheim-Chester disease involving the breast--a rare but important differential diagnosis.
    Guo S; Yan Q; Rohr J; Wang Y; Fan L; Wang Z
    Hum Pathol; 2015 Jan; 46(1):159-64. PubMed ID: 25454479
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeted therapy monitoring of BRAF-V600-mutant Erdheim-Chester disease by fast quantitative whole-body bone CZT-tomoscintigraphies.
    Melki S; Moulinet T; Verger A; Marie PY; Imbert L; Bahloul A
    Eur J Hybrid Imaging; 2023 Jan; 7(1):1. PubMed ID: 36635469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.